Search Media Coverage


To refine your search select a single option or a combination of options:

reset
 

Media Coverage

Displaying Media Coverage item(s) about Healthcare & Life Sciences
1/2/3/4/5Next 105 results
 
  • February 16, 2021
     
    Bloomberg Law
    Scientists at the Astellas Institute for Regenerative Medicine should be considered the sole inventors of three patents covering the production of human stem cells for medical use, a Boston federal court ruled.
     
    Share
    view
  • February 13, 2021
     
    Original Jurisdiction
    Latham honored for a huge trade secrets win for LG Energy Solution at the US International Trade Commission, a significant patent trial victory for Astellas, and the strength of the firm's global Private Equity Practice.
     
    Share
    view
  • February 09, 2021
     
    Law360
    A Massachusetts federal judge removed two former University of Connecticut scientists from a patent for an embryonic stem cell research method, ruling that they did not make inventive contributions.
     
    Share
    view
  • January 08, 2021
     
    Turnarounds & Workouts
    Global Vice Chair of Latham's Restructuring & Special Situations Practice named to Turnarounds & Workouts’ 2020 Outstanding Restructuring Lawyers list for successfully steering significant and highly complex matters in the last year.
     
    Share
    view
  • January 08, 2021
     
    Law360
    Steven Feldman brings a wide array of high-stakes litigation experience across industries to the firm’s battle-tested trial team.
     
    Share
    view
  • January 06, 2021
     
    Massachusetts Lawyers Weekly
    Boston Office Managing Partner is honored for his leadership and recent transactional work.
     
    Share
    view
  • December 02, 2020
     
    Law360
    Firm recognized for beating multiple big-ticket securities actions and helping pave the way for new law on forum selection provisions in initial public offering documents.
     
    Share
    view
  • November 23, 2020
     
    Law360
    The Federal Circuit affirmed a Delaware federal judge's ruling that Hospira's generic version of Par Pharmaceutical's epinephrine emergency allergy product Adrenalin infringes two valid patents covering the drug.
     
    Share
    view
  • November 09, 2020
     
    Daily Journal
    Global Chair of the Litigation & Trial Department honored as a leading national litigator who represents financial institutions, Fortune 500 companies, boards of directors, and individuals in securities, M&A, and other complex commercial litigation.
     
    Share
    view
  • November 05, 2020
     
    Daily Journal
    Global Vice Chair of the Healthcare & Life Sciences Practice honored for advising life sciences companies and investors in cutting edge, technology-based commercial transactions for development and commercialization of novel therapeutic and medical device products.
     
    Share
    view
  • November 02, 2020
     
    National Law Journal
    Firm recognized for tackling novel issues and securing “high-profile and high-stakes wins in the nation’s highest appellate courts across a number of practice areas.”
     
    Share
    view
  • October 28, 2020
     
    Law360
    Washington, D.C. partner recognized for securing a settlement with the US Department of Justice on behalf of a pharmaceutical client related to the sale and marketing of a pain management drug.
     
    Share
    view
  • September 10, 2020
     
    San Diego Daily Transcript
    Litigation & Trial partner recognized for advising healthcare industry clients in investigations and compliance matters.
     
    Share
    view
 
1/2/3/4/5Next
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.